Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autoantibody subclass predominance is not driven by aberrant class switching or impaired B cell development.
Paardekooper LM, Fillié-Grijpma YE, van der Sluijs-Gelling AJ, Zlei M, van Doorn R, Vermeer MH, Paunovic M, Titulaer MJ, van der Maarel SM, van Dongen JJM, Verschuuren JJ, Huijbers MG; T2B consortium. Paardekooper LM, et al. Among authors: van der sluijs gelling aj. Clin Immunol. 2023 Dec;257:109817. doi: 10.1016/j.clim.2023.109817. Epub 2023 Nov 2. Clin Immunol. 2023. PMID: 37925120 Free article.
Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome.
Najidh S, Tensen CP, van der Sluijs-Gelling AJ, Teodosio C, Cats D, Mei H, Kuipers TB, Out-Luijting JJ, Zoutman WH, van Hall T, Orfao A, Almeida J, van Dongen JJM, Vermeer MH. Najidh S, et al. Among authors: van der sluijs gelling aj. Blood. 2021 Dec 16;138(24):2539-2554. doi: 10.1182/blood.2021012286. Blood. 2021. PMID: 34314480 Free article.
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19.
Roukens AHE, Pothast CR, König M, Huisman W, Dalebout T, Tak T, Azimi S, Kruize Y, Hagedoorn RS, Zlei M, Staal FJT, de Bie FJ, van Dongen JJM, Arbous SM, Zhang JLH, Verheij M, Prins C, van der Does AM, Hiemstra PS, de Vries JJC, Janse JJ, Roestenberg M, Myeni SK, Kikkert M, Yazdanbakhsh M, Heemskerk MHM, Smits HH, Jochems SP; in collaboration with BEAT-COVID group; in collaboration with COVID-19 LUMC group. Roukens AHE, et al. Nat Immunol. 2022 Jan;23(1):23-32. doi: 10.1038/s41590-021-01095-w. Epub 2021 Dec 22. Nat Immunol. 2022. PMID: 34937933
Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood.
van der Pan K, de Bruin-Versteeg S, Damasceno D, Hernández-Delgado A, van der Sluijs-Gelling AJ, van den Bossche WBL, de Laat IF, Díez P, Naber BAE, Diks AM, Berkowska MA, de Mooij B, Groenland RJ, de Bie FJ, Khatri I, Kassem S, de Jager AL, Louis A, Almeida J, van Gaans-van den Brink JAM, Barkoff AM, He Q, Ferwerda G, Versteegen P, Berbers GAM, Orfao A, van Dongen JJM, Teodosio C. van der Pan K, et al. Among authors: van der sluijs gelling aj. Front Immunol. 2022 Sep 14;13:935879. doi: 10.3389/fimmu.2022.935879. eCollection 2022. Front Immunol. 2022. PMID: 36189252 Free PMC article.
No significant prognostic value of normal precursor B-cell regeneration in paediatric acute myeloid leukaemia after induction treatment.
Bras AE, van den Heuvel-Eibrink MM, van der Sluijs-Gelling AJ, Coenen EA, Wind H, Zwaan CM, te Marvelde JG, van der Burg M, Gibson B, Rijneveld AW, de Haas V, van Dongen JJ, van der Velden VH. Bras AE, et al. Br J Haematol. 2013 Jun;161(6):861-4. doi: 10.1111/bjh.12329. Epub 2013 Apr 12. Br J Haematol. 2013. PMID: 23577982 Free article.
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia.
Sędek Ł, Theunissen P, Sobral da Costa E, van der Sluijs-Gelling A, Mejstrikova E, Gaipa G, Sonsala A, Twardoch M, Oliveira E, Novakova M, Buracchi C, van Dongen JJM, Orfao A, van der Velden VHJ, Szczepański T; EuroFlow Consortium. Sędek Ł, et al. J Immunol Methods. 2019 Dec;475:112429. doi: 10.1016/j.jim.2018.03.005. Epub 2018 Mar 9. J Immunol Methods. 2019. PMID: 29530508
Comments on EuroFlow standard operating procedures for instrument setup and compensation for BD FACS Canto II, Navios and BD FACS Lyric instruments.
Glier H, Novakova M, Te Marvelde J, Bijkerk A, Morf D, Thurner D, Rejlova K, Lange S, Finke J, van der Sluijs-Gelling A, Sedek L, Flores-Montero J, Böttcher S, Fernandez P, Ritgen M, van Dongen JJM, Orfao A, van der Velden VHJ, Kalina T. Glier H, et al. J Immunol Methods. 2019 Dec;475:112680. doi: 10.1016/j.jim.2019.112680. Epub 2019 Oct 23. J Immunol Methods. 2019. PMID: 31655051
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study.
Lhermitte L, Barreau S, Morf D, Fernandez P, Grigore G, Barrena S, de Bie M, Flores-Montero J, Brüggemann M, Mejstrikova E, Nierkens S, Burgos L, Caetano J, Gaipa G, Buracchi C, da Costa ES, Sedek L, Szczepański T, Aanei CM, van der Sluijs-Gelling A, Delgado AH, Fluxa R, Lecrevisse Q, Pedreira CE, van Dongen JJM, Orfao A, van der Velden VHJ; EuroFlow Consortium. Lhermitte L, et al. Mod Pathol. 2021 Jan;34(1):59-69. doi: 10.1038/s41379-020-00677-7. Epub 2020 Sep 30. Mod Pathol. 2021. PMID: 32999413 Free PMC article.
Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients-A EuroFlow Study.
Bras AE, Matarraz S, Nierkens S, Fernández P, Philippé J, Aanei CM, de Mello FV, Burgos L, van der Sluijs-Gelling AJ, Grigore GE, van Dongen JJM, Orfao A, van der Velden VHJ, On Behalf Of The EuroFlow Consortium. Bras AE, et al. Among authors: van der sluijs gelling aj. Cancers (Basel). 2022 Apr 15;14(8):2011. doi: 10.3390/cancers14082011. Cancers (Basel). 2022. PMID: 35454917 Free PMC article.
28 results